Net Cash Provided by (Used in) Operating Activities |
2.2B |
USD |
-2.14% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
2.12B |
USD |
-18.6% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
3.6B |
USD |
+352% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
4B |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
834M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
22.7B |
USD |
+13% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
20M |
USD |
+11.1% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
3.07B |
USD |
+4.28% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
2.98B |
USD |
+0.54% |
Q1 2025 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
54M |
USD |
+100% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Issued |
1.25M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Authorized |
1.25M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Unrecognized Tax Benefits |
216M |
USD |
-10.7% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
9.8B |
USD |
+0.37% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
1.25M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Depreciation, Depletion and Amortization |
125M |
USD |
+5.04% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
3.05B |
USD |
+4.24% |
Q4 2024 |
FY 2024 |
Interest Expense |
4.14B |
USD |
+105% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |